European Archives - Page 64 of 1166 - European Medical Journal

Low CALLY Index Linked to Higher Mortality in Rheumatoid Arthritis

A new study reveals the C-reactive protein-albumin-lymphocyte (CALLY) index is a strong predictor of long-term survival in rheumatoid arthritis patients.

Buprenorphine Treatment Reduces Preterm Birth and NICU Admissions

A major study has shown that pregnant individuals treated with buprenorphine for opioid use disorder have lower risks of severe complications, preterm birth, and NICU admissions.

Mixed Reality Technology Improves Outcomes in Colon Cancer Surgery

New research highlights the benefits of using Mixed Reality (MR) technology during right hemicolectomy for colon cancer.

Mind Over Microbiota: Brain Rapidly Rewrites Gut Bacteria

Discover a study where researchers administered appetite-related hormones leptin and ghrelin directly into the brain.

Simple Blood Test Marker May Predict GI Cancer Risk

A new analysis from nearly 20,000 participants in the U.S. NHANES study has identified the platelet-to-high-density lipoprotein ratio (PHR) as a strong predictor of gastrointestinal cancer risk.

RCTs with Improved Evidence Certainty Needed for AP-DGBIs

Discover which treatments for abdominal pain-related disorders of gut-brain interaction are effective in this meta-analysis.

Global Registry Study Reveals Pregnancy Complications with Mechanical Heart Valves

Pregnancies with mechanical heart valves carry high risks, as a global registry reveals stark outcomes.

Analysis Reveals How Current Vaccination Rates Could Lead to Future Endemics

In this study, modelling predicts millions of cases of measle if vaccination rates continue to fall.

Carbohydrate Restriction Alone May Boost Cardiometabolic Health

New research finds that low-carb diets, even without calorie cuts, can mimic fasting’s metabolic effects — pointing to potential new strategies for improving heart and metabolic health.

Machine Learning Shows Impressive Bone Tumour Diagnosis Accuracy

AI-driven bone tumour classification model rivals expert radiologists, introducing BTI-RADS 2.0 for structured malignancy risk.